Article Name Invitro & Invivo Diagnostic

Chance Pharma’s CXG87 Moves Into China Regulatory Review for Asthma Treatment

The NMPA acceptance of Chance Pharma’s first new drug application advances CXG87, an improved budesonide/formoterol dry powder inhalation therapy, toward potential commercialisation in China.

08th May, 2026


Getting a leg up on diabetic lower extremity amputation with new AI risk prediction model

Jointly developed by SGH, SingHealth and MOHT, LEA-Net uses patient data to identify individuals at higher risk of lower extremity amputation three to five years before foot ulcers and infections develop.

08th May, 2026


Francis Medical Expands Commercial Use of Vanquish System for Prostate Tissue Ablation

Expansion of Vanquish procedures highlights growing adoption of minimally invasive water vapour ablation technology for prostate disease

07th May, 2026


Ribbon Bio Launches Cell-Free MiroSynth DNA and New In-Lab Cell-Free DNA Production Kit

Together, these announcements represent a step forward in increasing accessibility to complex DNA

06th May, 2026


Illuminant Surgical Secures $8.4M to Advance Image-Guided Surgery with “X-Ray Vision” Technology

Funding to accelerate development of real-time imaging solutions aimed at improving surgical precision and patient outcomes

30th April, 2026


Calidar Advances Breast Cancer Imaging with Completion of First-in-Human Study Enrollment for 4D Mammography System

Calidar completes enrollment in a first-in-human study of its 4D Mammography system, advancing a next-generation imaging platform designed to enhance breast cancer detection through molecular-level diagnostics.

29th April, 2026


The Neuron Clinic Expands Brain PET Capabilities with Additional NeuroLF Systems to Advance Alzheimer’s Diagnosis

Deployment of compact point-of-care brain PET scanners reflects growing demand for earlier, accessible neurodiagnostics in community settings

24th April, 2026


How Inhaled Microplastics Impact Lung Function and Respiratory Health

The respiratory system has evolved efficient mechanisms to clear inhaled particles

23rd April, 2026


Non-Invasive Oncology Takes Center Stage at Sonire Therapeutics

The company is seeking to overcome long-standing limitations of conventional HIFU systems and expand the role of non-invasive therapies in clinical practice

22nd April, 2026


Genentech Advances Gazyva® for Lupus with FDA Acceptance of New Application

Regulatory milestone expands potential use of anti-CD20 therapy in lupus, building on prior success in lupus nephritis

21st April, 2026


Bracco Secures Health Canada Approval for Vueway® to Advance Lower-Dose MRI Contrast Imaging

Gadopiclenol-based contrast agent enables high-quality imaging at reduced gadolinium exposure, supporting safer diagnostic workflows

20th April, 2026


CStone Reveal Preclinical Data on Next-Generation ADCs Targeting EGFR/HER3 and Tumor Heterogeneity

CStone presents preclinical data on three differentiated antibody-drug conjugates, including a dual-target EGFR/HER3 candidate

20th April, 2026


New Alpha Radiopharmaceutical Imaging Platform Aims to Improve In Vivo Therapy Visualisation

α-Sight™ integrates advanced SPECT imaging, radiochemistry, and quantitative analysis to enable precise tracking of alpha-emitting therapies

16th April, 2026


FertilAI Secures CE Mark for Predictive AI in Fertility Treatment Optimisation

AI will soon enable clinicians to predict ovulation and optimize IVF cycle timing, improving outcomes and operational efficiency.

16th April, 2026


Cepheid And Oxford Nanopore Expand Partnership To Advance Rapid Genomic Workflow For Sepsis Research

Phase two collaboration aims to expand access to streamlined genomic workflows for infectious disease research

15th April, 2026


Invivoscribe Elevates Molecular Diagnostics With PrepQuant System To Standardise And Accelerate Sample Preparation

Integrated automated platform unifies multi step sample preparation to improve consistency, reduce operational complexity, and enable high precision workflows across MRD testing and advanced molecular diagnostics

15th April, 2026


Premier Radiology Services Acquires Global Imaging Solutions

These strengths enhance our platform and position us to meet the growing demand for high-quality teleradiology services in outpatient imaging

02nd April, 2026


Advancing Global Diagnostics with Expanded Immunoassay Testing Solutions

QuidelOrtho is strengthening its global immunoassay offering through a new partnership aimed at expanding assay availability beyond its existing VITROS diagnostic system portfolio

12th March, 2026


Medtech Special

© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer